The Coronary Drug Project: implications for clinical care.
D002994:Clofibrate / Q000494:pharmacology; D003918:Dextrothyroxine / Q000009:adverse effects; D004967:Estrogens / Q000494:pharmacology; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology; D009539:Nicotinic Acids / Q000494:pharmacology; D011379:Prognosis; D012907:Smoking / Q000150:complications
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D003918:Dextrothyroxine; D002994:Clofibrate